Using the Optovue OCT to Select IOL Power
Evaluation of Total Corneal Power Calculations for Intraocular Lens Selection Using the Optovue OCT in Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK) Patients
Sponsor: Devers Eye Institute
Terminated
The DSAEK procedure was discontinued as the standard of care for the intended cohort.
Other Cataract trials with similar outcome
Listed as NCT01361282, this observational or N/A phase trial focuses on Cataract and Fuchs' Endothelial Dystrophy and remains terminated or withdrawn. Sponsored by Devers Eye Institute, it has been updated 9 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated
-
Jul 2024 — Sep 2024 [monthly]
Terminated
-
Jan 2021 — Jul 2024 [monthly]
Terminated
-
Aug 2020 — Jan 2021 [monthly]
Terminated
-
Jun 2018 — Aug 2020 [monthly]
Terminated
▶ Show 4 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Terminated
Phase: NA → None
-
May 2017 — Apr 2018 [monthly]
Terminated NA
Status: Unknown Status → Terminated
-
Feb 2017 — May 2017 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation NA
First recorded
Nov 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Devers Eye Institute
- Legacy Health System
- Lions VisionGift Research
- Optovue
For direct contact, visit the study record on ClinicalTrials.gov .